Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases

BACKGROUND: Anti-PD-1 has activity in brain metastases (BM). This phase II open labeled non-randomized single arm trial examined the safety and efficacy of combining nivolumab with radiosurgery (SRS) in the treatment of patients with BM from non-small cell lung cancer (NSCLC) and renal cell carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Philip, Masucci, Laura, Florescu, Marie, Plourde, Marc-Emile, Panet-Raymond, Valerie, Pavic, Michel, Owen, Scott, Masson-Coté, Laurence, Ménard, Cynthia, Routy, Bertrand, Tehfe, Mustapha, Nelson, Kristoff, Guilbert, Francois, Boucher, Olivier, Keshavarzi, Sareh, Blais, Normand, Roberge, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072191/
https://www.ncbi.nlm.nih.gov/pubmed/37025758
http://dx.doi.org/10.1093/noajnl/vdad018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072191/
https://www.ncbi.nlm.nih.gov/pubmed/37025758
http://dx.doi.org/10.1093/noajnl/vdad018

Ejemplares similares